Hippocampal seizure discharge produced by systemic digitoxigenin is antagonized by reserpine or p-chlorophenylalanine

Neuropharmacology. 1982 Jan;21(1):95-8. doi: 10.1016/0028-3908(82)90218-0.

Abstract

EEG was recorded from several brain regions during the i.v. infusion of digitoxigenin to conscious, freely-moving rats. Two seizure episodes were recorded from the ventral hippocampus with the second, more severe seizure characterized by low-frequency (3-6/sec), high-amplitude (0.9-1.5 mV) discharges. Secondary activity was recorded from the mesencephalic and reticular formations. Pretreatment of rats with p-chlorophenylalanine or reserpine prevented the first seizure and markedly delayed the second seizure to appear after 1.85 mg or 4.66 mg digitoxigenin/kg, respectively, compared to 0.79 mg/kg in untreated rats. The pretreatments did not alter the frequency of the discharges but reduced their amplitude to 0.4 -0.75 mV. The results suggest a role for monoamines, and in particular serotonin, in the effect of digitoxigenin to cause hippocampal seizure discharge.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Digitoxigenin / antagonists & inhibitors*
  • Digitoxigenin / pharmacology
  • Fenclonine / pharmacology*
  • Hippocampus / drug effects*
  • Hippocampus / physiopathology
  • Male
  • Rats
  • Rats, Inbred Strains
  • Reserpine / pharmacology*
  • Seizures / chemically induced
  • Seizures / prevention & control*

Substances

  • Digitoxigenin
  • Reserpine
  • Fenclonine